• Study of immunobiotic lactic acid bacteria and their cell fractions as an alternative for the development of immunomodulatory products intended for the prevention of respiratory infections in immunocompromised hosts.
  • Immunobiotic lactic acid bacteria in the prevention of bacterial and viral respiratory infections. Study of its mechanisms of action using cutting-edge molecular tools and genomic studies.
  • Identification of recognition patterns and signaling pathways involved in the prevention of respiratory superinfections using immuno-modulatory fractions of lactic acid bacteria.
  • Immunobiotic lactic acid bacteria in the recovery of hematopoiesis in immunosuppressed hosts due to malnutrition or chemotherapy.
  • Impact of immunopotentiating lactic acid bacteria in the immuno-myelopoietic response during infectious / inflammatory processes in immuno-compromised hosts.
  • Expression of antigenic proteins of respiratory pathogens in recombinant lactic bacteria for their potential use as vectors of vaccines.
  • Study of immuno-modulatory molecules of immuno-biotic lactic acid bacteria for their use as adjuvants in the development of mucous vaccines.
  • Effect of immunobiolactic acid bacteria on the interrelation inflammation-hemostasis and its impact on resistance to bacterial and viral respiratory infections.
  • Study of commensal bacteria of the respiratory tract as new generation immuno-biotics to improve respiratory health.
  • Immuno-modulatory capacity of lactic acid bacteria on intra-hepatic innate immunity in inflammatory diseases of the liver.